Sep 14, 2018
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.26 to $7.80.
The split itself did not change the total investment value.
Altimmune, Inc. (NASDAQ:ALT) operates in the Biotechnology industry.
Altimmune, Inc. company overviewAltimmune, Inc.'s most recent stock split was on September 14, 2018. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
Altimmune, Inc. (NASDAQ:ALT) has split its stock 2 times: a 1-for-10 reverse split on May 5, 2017 and a 1-for-30 reverse split on September 14, 2018.
Altimmune, Inc. has split its stock 2 times. This history records 2 reverse splits between May 5, 2017 and September 14, 2018.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Altimmune, Inc.'s 1-for-30 reverse split on September 14, 2018, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Altimmune, Inc. has not announced a new split in our records. Its most recent split was on September 14, 2018, 8 years ago. Companies announce splits in advance, and any new NASDAQ:ALT split will appear on this page.